EUR 0.42
(5.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | 31 Million | -60.1 Million | 78.06 Million | 251.34 Million | 15.39 Million |
Net Income | -714.6 Million | -187.9 Million | -38.1 Million | 120.43 Million | 117.86 Million | 62.98 Million |
Depreciation & Amortization | - | 214.3 Million | 54.7 Million | 31.1 Million | 25.98 Million | 20.85 Million |
Deferred income taxes | - | - | - | -49.4 Million | -25.28 Million | -22.83 Million |
Stock-based compensation | - | 3.5 Million | 1.2 Million | 1.9 Million | 1.46 Million | 1.15 Million |
Change in working capital | - | 24.8 Million | -73.2 Million | -49.5 Million | 109.25 Million | -64.46 Million |
Other non-cash items | 714.6 Million | -23.7 Million | -4.7 Million | 23.48 Million | 22.06 Million | 17.68 Million |
Investing Cash Flow | - | 9.8 Million | -32.8 Million | -88.27 Million | -47.73 Million | -145.61 Million |
Investments in PPE | - | -900 Thousand | -6.5 Million | -16.56 Million | -10.1 Million | -2.26 Million |
Acquisitions | - | 7.5 Million | -24 Million | 16.64 Million | -11.41 Million | -147.78 Million |
Investment purchases | - | -1.7 Million | -22.7 Million | -119.48 Million | -55.01 Million | -46.02 Million |
Sales/Maturities of investments | - | 3.4 Million | 20.1 Million | 27.49 Million | 26.98 Million | 46.44 Million |
Other Investing Activities | - | 1.5 Million | 300 Thousand | 3.63 Million | 1.81 Million | 4.02 Million |
Financing Cash Flow | - | -56.2 Million | 78.3 Million | -80.89 Million | -116.26 Million | 191.58 Million |
Debt repayment | - | -39.5 Million | -3.1 Million | -1.9 Million | -365.21 Million | -176 Million |
Dividends payments | - | - | - | -52.93 Million | -42.58 Million | -13.6 Million |
Common Stock Repurchased | - | - | - | -6.68 Million | - | 355.16 Million |
Common Stock Issuance | - | - | 78.6 Million | -29.44 Million | - | 22.71 Million |
Other Financing Activities | - | -16.7 Million | 2.8 Million | 10.07 Million | 291.53 Million | 3.31 Million |
Accounts receivables | - | 21.4 Thousand | -74.4 Thousand | -82.2 Thousand | - | -103.93 Thousand |
Accounts payables | - | -21.4 Thousand | 74.4 Thousand | -49.45 Million | - | - |
Inventory | - | -18.6 Million | -12.2 Million | -73.2 Thousand | -16.17 Million | -68.26 Million |
Other working capital | - | 43.4 Million | -61 Million | 105.9 Thousand | 125.42 Million | 3.8 Million |
Cash at beginning of period | 75.7 Million | 91.2 Million | 105.8 Million | 196.92 Million | 109.57 Million | 48.2 Million |
Cash at end of period | 55.9 Million | 75.7 Million | 91.2 Million | 105.81 Million | 196.92 Million | 109.57 Million |
Capital Expenditure | - | -900 Thousand | -6.5 Million | -16.56 Million | -10.1 Million | -2.26 Million |
Effect of forex changes on cash | - | -100 Thousand | - | - | -1000.00 | 1000.00 |
Net cash flow / Change in cash | -19.8 Million | -15.5 Million | -14.6 Million | -91.1 Million | 87.34 Million | 61.36 Million |
Free Cash Flow | - | 30.1 Million | -66.6 Million | 61.49 Million | 241.24 Million | 13.12 Million |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | -132.69 Million | -714.6 Million | -59.2 Million |
Depreciation & Amortization | - | - | - | - | - | 76.1 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | -4.3 Million |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | 132.69 Million | 714.6 Million | 63.5 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | 55.9 Million | 41.9 Million | 75.7 Million | 61.4 Million |
Cash at end of period | - | - | 55.9 Million | 55.9 Million | 55.9 Million | 41.9 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | 14 Million | -19.8 Million | -19.5 Million |
Free Cash Flow | - | - | - | - | - | 152.2 Million |
SURYALAXMI
RFA
CNOBF
5236
TTMZF
EVKG